Items 111 to 120 of 168 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Dalbavancin | 171500-79-1 | sc-391787 | 1 mg | $128.00 | 1 | |
Dalbavancin is a glycopeptide antibiotic characterized by its unique binding to bacterial cell wall precursors, specifically inhibiting transglycosylation and transpeptidation processes. This interaction disrupts peptidoglycan synthesis, leading to cell lysis. Its extended half-life allows for prolonged activity, while its lipophilic nature enhances membrane permeability. The compound's stability against enzymatic degradation further contributes to its effectiveness in targeting resistant strains, showcasing distinct kinetic properties in bacterial inhibition. | ||||||
N-(2-Cyanoethyl)-N-methylacetamide | sc-329063 | 500 mg | $270.00 | |||
N-(2-Cyanoethyl)-N-methylacetamide exhibits intriguing interactions at the molecular level, particularly through its ability to form hydrogen bonds and engage in dipole-dipole interactions. This compound can influence metabolic pathways by acting as a substrate for various enzymatic reactions, potentially altering reaction kinetics. Its polar nature enhances solubility in aqueous environments, facilitating interactions with biological macromolecules, which may lead to unique biochemical effects. | ||||||
Doxycycline ssa | 369-95-9 | sc-279009 | 1 g | $700.00 | 3 | |
Doxycycline ssa demonstrates notable characteristics through its chelating ability, forming stable complexes with metal ions, which can modulate catalytic activity in biochemical systems. Its unique structure allows for effective π-π stacking interactions, enhancing its stability in various environments. Additionally, the compound's amphipathic nature promotes interactions with lipid membranes, influencing permeability and transport mechanisms, thereby affecting cellular dynamics and molecular behavior. | ||||||
Methacycline | 914-00-1 | sc-279308 | 10 mg | $133.00 | ||
Methacycline exhibits distinctive properties through its ability to form hydrogen bonds, which can influence solubility and reactivity in various chemical environments. Its planar structure facilitates strong π-π interactions, contributing to its stability and potential aggregation in solution. Furthermore, the compound's hydrophobic regions enhance its affinity for nonpolar solvents, impacting its distribution and interaction with biological membranes, thereby affecting its overall chemical behavior. | ||||||
Clindamycin palmitate HCL | 25507-04-4 | sc-278863 | 50 mg | $195.00 | ||
Clindamycin palmitate HCL demonstrates unique characteristics through its amphiphilic nature, allowing it to interact effectively with both polar and nonpolar environments. The presence of palmitate enhances its lipophilicity, promoting membrane penetration and influencing its distribution in various media. Additionally, the compound's ability to engage in van der Waals interactions contributes to its stability in solution, while its ionic form can facilitate specific electrostatic interactions, affecting its reactivity and solubility profiles. | ||||||
Cefmenoxime hydrochloride | 75738-58-8 | sc-278818 | 25 mg | $196.00 | ||
Cefmenoxime hydrochloride is a cephalosporin antibiotic characterized by its ability to disrupt bacterial cell wall synthesis through selective binding to penicillin-binding proteins. This interaction triggers a cascade of events that compromises cell integrity, leading to cell death. Its unique structural modifications enhance resistance to hydrolysis by beta-lactamases, allowing it to maintain efficacy against certain resistant bacteria. The compound's solubility and stability contribute to its effective performance in various environments. | ||||||
Azlocillin | 37091-66-0 | sc-337545 | 10 g | $1400.00 | ||
Azlocillin exhibits distinctive properties as a beta-lactam antibiotic, characterized by its ability to bind to penicillin-binding proteins (PBPs) in bacterial cell walls. This interaction disrupts peptidoglycan synthesis, leading to cell lysis. Its unique side chain enhances stability against certain beta-lactamases, allowing for broader spectrum activity. The compound's hydrophilic nature facilitates solubility in aqueous environments, influencing its diffusion and bioavailability in various biological systems. | ||||||
Cefotiam | 61622-34-2 | sc-278821 | 100 mg | $700.00 | ||
Cefotiam is a cephalosporin antibiotic that showcases unique interactions with bacterial enzymes, particularly through its affinity for transpeptidases. This binding inhibits cross-linking in the peptidoglycan layer, compromising cell wall integrity. Its structural modifications enhance resistance to hydrolysis by beta-lactamases, while its zwitterionic nature improves solubility and permeability across bacterial membranes, facilitating effective distribution in target environments. | ||||||
Cefuroxime axetil | 64544-07-6 | sc-278826 | 100 mg | $200.00 | ||
Cefuroxime axetil is a broad-spectrum cephalosporin that exhibits distinctive interactions with bacterial cell wall synthesis pathways. Its acylated structure allows for enhanced stability against hydrolytic enzymes, promoting prolonged activity. The compound's lipophilic characteristics facilitate passive diffusion through lipid membranes, optimizing its bioavailability. Additionally, its unique ester bond configuration contributes to its pharmacokinetic profile, influencing absorption and distribution in biological systems. | ||||||
Cefmenoxime | 65085-01-0 | sc-278817 | 10 mg | $700.00 | ||
Cefmenoxime is a cephalosporin antibiotic characterized by its unique ability to inhibit bacterial cell wall synthesis through binding to penicillin-binding proteins. Its structural modifications enhance resistance to beta-lactamases, allowing for effective action against resistant strains. The compound's hydrophilic nature aids in solubility, while its specific stereochemistry influences interaction dynamics with target enzymes, impacting its overall efficacy and stability in various environments. |